Assertion: ligand | /r/CapableOf | sell right
Facets:
value: for 827 million
type: TRANSITIVE-OBJECT
value: in march
type: TEMPORAL
value: to privately-held royalty pharma
type: TRANSITIVE-OBJECT
Source sentences:
text: In March, Ligand sold all rights to Promacta, including royalty rights to worldwide net sales, to privately-held Royalty Pharma for $827 million.